Neuroone Medical Technologies (NMTC) Operating Leases (2019 - 2026)
Neuroone Medical Technologies (NMTC) posted Operating Leases of $92361.0 for Q1 2026, down 16.32% on a QoQ basis from $110374.0 in Q4 2025, and down 55.38% year-over-year from $206973.0 in Q1 2025.
Neuroone Medical Technologies (NMTC) Operating Leases (2019 - 2026) Analysis & Trends
Neuroone Medical Technologies' Operating Leases history runs 8 years deep, the most recent figure standing at $92361.0 for Q1 2026.
- Quarterly Operating Leases fell 55.38% year-over-year to $92361.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $92361.0 (down 55.38% YoY) and the FY2025 annual result came in at $143148.0, down 26.36% from the prior year.
- Operating Leases was $92361.0 for Q1 2026 at Neuroone Medical Technologies, down from $110374.0 in the prior quarter.
- Across five years, Operating Leases topped out at $243980.0 in Q1 2023 and bottomed at $20982.0 in Q4 2023.
- A 5-year average of $154492.9 and a median of $154882.0 in 2022 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2023 — Operating Leases tumbled 86.35% — and 2024, when it soared 1031.34%.
- Neuroone Medical Technologies' Operating Leases stood at $153721.0 in 2022, then tumbled by 86.35% to $20982.0 in 2023, then surged by 1031.34% to $237377.0 in 2024, then sank by 53.5% to $110374.0 in 2025, then retreated by 16.32% to $92361.0 in 2026.
- Business Quant data shows NMTC's Operating Leases at $92361.0 in Q1 2026, $110374.0 in Q4 2025, and $143148.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Neuroone Medical Technologies | 7.99 Mn | 5.19 Mn | 990,264.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 92,361.00 |
| Dec 31, 2025 | 110,374.00 |
| Sep 30, 2025 | 143,148.00 |
| Jun 30, 2025 | 175,344.00 |
| Mar 31, 2025 | 206,973.00 |
| Dec 31, 2024 | 237,377.00 |
| Sep 30, 2024 | 194,392.00 |
| Jun 30, 2024 | 209,910.00 |
| Dec 31, 2023 | 20,982.00 |
| Sep 30, 2023 | 55,284.00 |
| Jun 30, 2023 | 214,482.00 |
| Mar 31, 2023 | 243,980.00 |
| Dec 31, 2022 | 153,721.00 |
| Sep 30, 2022 | 119,556.00 |
| Jun 30, 2022 | 137,959.00 |
| Mar 31, 2022 | 156,043.00 |
| Dec 31, 2021 | 173,314.00 |
| Sep 30, 2021 | 202,895.00 |
| Jun 30, 2021 | 206,966.00 |
| Mar 31, 2021 | 223,357.00 |